piribedil has been researched along with Amentia in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oules, MJ | 1 |
| Boscredon, J | 1 |
| Scholing, WE | 1 |
| Clausen, HD | 1 |
1 trial available for piribedil and Amentia
| Article | Year |
|---|---|
[Psychological studies of a long-term treatment of the neurovascular syndrom with Trivastal (author's tranls)].
Topics: Aged; Analysis of Variance; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical | 1975 |
1 other study available for piribedil and Amentia
| Article | Year |
|---|---|
[Clinical study of cerebral dopaminergic mechanisms: the action of piribedil in psychiatry. Initial results].
Topics: Adjustment Disorders; Aged; Dementia; Depression; Humans; Middle Aged; Piperazines; Piribedil | 1979 |